Drug Database
Back to search

Poland· PL-100316042

Sustiva

A efavirenz product containing efavirenzum, registered in Poland by Bristol-Myers Squibb Pharma EEIG. The same ATC class is registered in 16 of our 19 countries.

ATC J05AG03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSustivaATCJ05AG03REGISTER NO.PL-100316042PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about efavirenzumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Efavirenz is registered in 16 of 19 countries.

Countries holding a registration under ATC J05AG03 (efavirenz), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search efavirenz products by name

Efavirenz · ATC J05AG03

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of efavirenz costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), the median price runs from $9.90 in Switzerland to $66.82 in France — a ×6.7 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Efavirenz · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

  • FR France$66.82
  • CH Switzerland$9.90
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Efavirenzum
Manufacturer
Bristol-Myers Squibb Pharma EEIG
Country
Poland (PL)
ATC code
J05AG03
ATC class
Efavirenz
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

486 interactions on record for efavirenz.

Graded by severity as the source publishes them — 137 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check efavirenz against other medicinesHow interaction checks work

Efavirenz · interactions on record

486 records

  • 137 severe
  • 278 moderate
  • 8 minor
  • 48 info

Most severe, free to view

  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe

15 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Efavirenz in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All efavirenz products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Efavirenz Sandoz
  • Belgium · Efavirenz Viatris
  • Cyprus · Efavirenz Aurobindo
  • Germany · Efavirenz Aurobindo
  • Denmark · Efavirenz "sandoz", Efavirenz Aurobindo
  • Estonia · Efavirenz Sandoz
  • Spain · Efavirenz Aurovitas
  • Finland · Efavirenz Aurobindo, Efavirenz Sandoz
  • France · Efavirenz Arrow, Efavirenz Sandoz
  • United Kingdom (Northern Ireland) · Efavirenz Accord, Efavirenz Amarox
  • Iceland · Efavirenz Teva
  • Liechtenstein · Efavirenz Teva
  • Netherlands · Efavirenz Accord, Efavirenz Aurobindo
  • Norway · Efavirenz Sandoz, Efavirenz Teva
  • Portugal · Efavirenz Aurobindo, Efavirenz Farmoz
  • Sweden · Efavirenz Aurobindo, Efavirenz Medical Valley

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/550d5588-e8de-49b3-8c77-59b12f3b2cb8
GET /v1/drugs/550d5588-e8de-49b3-8c77-59b12f3b2cb8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "50 mg",
  "packaging": "Rpz ¦ EU/1/99/110/001 ¦ 91432\n1 butelka 30 kaps.",
  "substance": "Efavirenzum 50 mg",
  "common_name": "Efavirenzum",
  "pl_product_id": "100316042",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": "2024-02-01"
}
API referenceMCP serverPlans

See everything about efavirenz.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console